University of East Anglia
Norwich Research Park, Norwich, Norfolk, NR4 7TJ, United Kingdom
Overview
The University of East Anglia (UEA) has once again been rated as one of the best universities for student experience in the Times Higher Education Student Experience Survey 2016. We are currently 7th out of all UK universities. In addition to being consistently in the top ten for student satisfaction, UEA is ranked in the top one per cent of universities in the world. We are an internationally renowned university based in a campus that provides top quality academic, social and cultural facilities to over 15,000 students. The campus is located in 320 acres of rolling parkland just two miles from the centre of Norwich, the cathedral city, and England’s first UNESCO City of Literature. This uniquely-placed University is also a leading member of Norwich Research Park, one of Europe's biggest concentrations of researchers in the fields of environment, health and plant science. Sporting facilities on campus include the University Sportspark which houses an Olympic-sized swimming pool and regularly hosts international sporting events. UEA also has the world famous Sainsbury Centre for Visual Arts and hosts an International Literary Festival which has included famous names such as Ian McEwan, Kazuo Ishiguro and Anne Enright (all alumni of UEA's Creative Writing course).
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Education
- Higher Education
- Universities
Investment portfolio
- Evaro
Participated · Seed · Jan 2024
Evaro is an NHS-licensed digital healthcare platform founded by medical professionals to embed regulated online care within consumer brands’ existing digital experiences. Its healthcare-as-a-service stack covers asynchronous consultations, remote diagnostics, prescribing, dispensing and aftercare, and can be integrated in a short timeframe with minimal engineering lift for partners. The system supports treatment across more than 80 common conditions and has already served over two million patients through various consumer-facing brands. By enabling trusted non-clinical companies to add healthcare offerings, Evaro creates new revenue streams and deeper customer engagement while helping relieve pressure on overstretched UK primary care. The company generates income from these brand partnerships, though detailed revenue figures were not disclosed. With fresh capital in hand, Evaro intends to expand its reach and further develop its infrastructure for the UK market. The new funding round signals investor confidence in the firm’s traction and its ability to scale regulated digital healthcare delivery.